Seropositivity of COVID-19 among asymptomatic healthcare workers: A multi-site prospective cohort study from Northern Virginia, United States.
CIA, Chemiluminescent immunoassay
COVID-19
COVID-19, Coronavirus disease 2019
HCW, Healthcare worker
Immunity
PPE, Personal protective equipment
SARS-CoV-2, severe acute respiratory syndrome coronavirus 2
Serologic test
ZIP, Zone Improvement Plan
Journal
Lancet regional health. Americas
ISSN: 2667-193X
Titre abrégé: Lancet Reg Health Am
Pays: England
ID NLM: 9918232503006676
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
19
04
2021
revised:
30
06
2021
accepted:
13
07
2021
pubmed:
14
8
2021
medline:
14
8
2021
entrez:
13
8
2021
Statut:
ppublish
Résumé
Because of their direct patient contact, healthcare workers (HCW) face an unprecedented risk of exposure to COVID-19. The aim of this study was to examine incidence of COVID-19 disease among asymptomatic HCW and community participants in Northern Virginia during 6 months of follow-up. This is a prospective cohort study that enrolled healthy HCW and residents who never had a symptomatic COVID-19 infection prior to enrolment from the community in Northern Virginia from April to November 2020. All participants were invited to enrol in study, and they were followed at 2-, and 6-months intervals. Participants were evaluated by commercial chemiluminescence SARS-CoV-2 serology assays as part of regional health system and public health surveillance program to monitor the spread of COVID-19 disease. Of a total of 1,819 asymptomatic HCW enrolled, 1,473 (96%) had data at two-months interval, and 1,323 (73%) participants had data at 6-months interval. At baseline, 21 (1.15%) were found to have prior COVID-19 exposure. At two-months interval, COVID-19 rate was 2.8% and at six months follow-up, the overall incidence rate increased to 4.8%, but was as high as 7.9% among those who belong to the youngest age group (20-29 years). Seroconversion rates in HCW were comparable to the seropositive rates in the Northern Virginia community. The overall incidence of COVID-19 in the community was 4.5%, but the estimate was higher among Hispanic ethnicity (incidence rate = 15.3%) potentially reflecting different socio-economic factors among the community participants and the HCW group. Using cross-sectional logistic regression and spatio-temporal mixed effects models, significant factors that influence the transmission rate among HCW include age, race/ethnicity, resident ZIP-code, and household exposure, but not direct patient contact. In Northern Virginia, the seropositive rate of COVID-19 disease among HCW was comparable to that in the community.
Sections du résumé
BACKGROUND
BACKGROUND
Because of their direct patient contact, healthcare workers (HCW) face an unprecedented risk of exposure to COVID-19. The aim of this study was to examine incidence of COVID-19 disease among asymptomatic HCW and community participants in Northern Virginia during 6 months of follow-up.
METHODS
METHODS
This is a prospective cohort study that enrolled healthy HCW and residents who never had a symptomatic COVID-19 infection prior to enrolment from the community in Northern Virginia from April to November 2020. All participants were invited to enrol in study, and they were followed at 2-, and 6-months intervals. Participants were evaluated by commercial chemiluminescence SARS-CoV-2 serology assays as part of regional health system and public health surveillance program to monitor the spread of COVID-19 disease.
FINDINGS
RESULTS
Of a total of 1,819 asymptomatic HCW enrolled, 1,473 (96%) had data at two-months interval, and 1,323 (73%) participants had data at 6-months interval. At baseline, 21 (1.15%) were found to have prior COVID-19 exposure. At two-months interval, COVID-19 rate was 2.8% and at six months follow-up, the overall incidence rate increased to 4.8%, but was as high as 7.9% among those who belong to the youngest age group (20-29 years). Seroconversion rates in HCW were comparable to the seropositive rates in the Northern Virginia community. The overall incidence of COVID-19 in the community was 4.5%, but the estimate was higher among Hispanic ethnicity (incidence rate = 15.3%) potentially reflecting different socio-economic factors among the community participants and the HCW group. Using cross-sectional logistic regression and spatio-temporal mixed effects models, significant factors that influence the transmission rate among HCW include age, race/ethnicity, resident ZIP-code, and household exposure, but not direct patient contact.
INTERPRETATION
CONCLUSIONS
In Northern Virginia, the seropositive rate of COVID-19 disease among HCW was comparable to that in the community.
Identifiants
pubmed: 34386793
doi: 10.1016/j.lana.2021.100030
pii: S2667-193X(21)00022-3
pmc: PMC8319689
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100030Informations de copyright
© 2021 The Author(s). Published by Elsevier Ltd.
Références
J Infect Dis. 2021 May 28;223(10):1677-1680
pubmed: 33718952
Ann Med Surg (Lond). 2020 Jul 11;57:14-16
pubmed: 32690991
Annu Rev Public Health. 2012 Apr;33:107-22
pubmed: 22429160
Ann Intern Med. 2021 Apr;174(4):W45-W46
pubmed: 33556273
Am J Clin Pathol. 2020 Nov 4;154(6):742-747
pubmed: 32864699
Int J Health Geogr. 2010 Jun 29;9:33
pubmed: 20587045
BMJ. 2020 Oct 28;371:m3582
pubmed: 33115726
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Int J Infect Dis. 2021 Jan;102:239-241
pubmed: 33130210
Ann Intern Med. 2020 Sep 1;173(5):362-367
pubmed: 32491919
Lancet Infect Dis. 2020 Sep;20(9):e245-e249
pubmed: 32687805
Clin Microbiol Infect. 2020 Oct;26(10):1413.e9-1413.e13
pubmed: 32569835
N Engl J Med. 2021 Feb 11;384(6):533-540
pubmed: 33369366
Biometrika. 1950 Jun;37(1-2):17-23
pubmed: 15420245
N Engl J Med. 2020 Mar 26;382(13):1268-1269
pubmed: 32109011
JAMA Netw Open. 2021 Feb 1;4(2):e2035234
pubmed: 33555331
BMJ. 2020 Oct 28;371:m3944
pubmed: 33115772
Ann Intern Med. 2021 Jan;174(1):W18-W19
pubmed: 33226856
JAMA. 2020 Jul 14;324(2):195-197
pubmed: 32539107
PLoS One. 2015 May 19;10(5):e0126158
pubmed: 25993120
Int J Infect Dis. 2021 Mar;104:335-346
pubmed: 33444754
J Am Heart Assoc. 2021 Feb;10(5):e019506
pubmed: 33619984